pentylenetetrazole has been researched along with Alloxan Diabetes in 3 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yorulmaz, H | 1 |
| Kaptan, E | 1 |
| Seker, FB | 1 |
| Oztas, B | 2 |
| Ghasemi, M | 1 |
| Shafaroodi, H | 1 |
| Karimollah, AR | 1 |
| Gholipour, T | 1 |
| Nezami, BG | 1 |
| Ebrahimi, F | 1 |
| Dehpour, AR | 1 |
| Oner, P | 1 |
| Koçak, H | 1 |
3 other studies available for pentylenetetrazole and Alloxan Diabetes
| Article | Year |
|---|---|
Type 1 diabetes exacerbates blood-brain barrier alterations during experimental epileptic seizures in an animal model.
Topics: Animals; Astrocytes; Blood Glucose; Blood Pressure; Blood-Brain Barrier; Convulsants; Cytokines; Dia | 2015 |
ATP-sensitive potassium channels contribute to the time-dependent alteration in the pentylenetetrazole-induced seizure threshold in diabetic mice.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Cromakalim; Diabetes Mellitus, Experiment | 2010 |
Brain cortex Na(+)-K+ ATPase activities in streptozotocin-diabetic and pentylenetetrazol-epileptic rats.
Topics: Animals; Cerebral Cortex; Convulsants; Diabetes Mellitus, Experimental; Epilepsy; Pentylenetetrazole | 1997 |